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Background: Evaluation of the quality of antenatal care (ANC) using indicators should be part of the efforts to
improve primary care services in developing countries. The growing use of the electronic health record (EHR) has
the potential of making the evaluation more efficient. The objectives of this study were: (a) to develop quality
indicators for ANC and (b) to evaluate the quality of ANC using EHR information in family medicine clinics (FMCs) of
Mexico City.
Methods: We used a mixed methods approach including: (a) in-depth interviews with health professionals; (b)
development of indicators following the RAND-UCLA method; (c) a retrospective cohort study of quality of care
provided to 5342 women aged 12–49 years who had completed their pregnancy in 2009 and attended to at
least one ANC visit with their family doctor. The study took place in four FMCs located in Mexico City. The source
of information was the EHR. SAS statistical package served for programing and performing the descriptive
statistical analysis.
Results: 14 ANC quality indicators were developed. The evaluation showed that 40.6% of women began ANC in
the first trimester; 63.5% with low-risk pregnancy attended four or more ANC visits; 4.4% were referred for
routine obstetric ultrasound, and 41.1% with vaginal infection were prescribed metronidazole. On average, the
percentage of recommended care that women received was 32.7%.
Conclusions: It is feasible to develop quality indicators suitable for evaluating the quality of ANC using routine
EHR data. The study identified the ANC areas that require improvement; which can guide future strategies
aimed at improving ANC quality.
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Evidence-based antenatal care (ANC) is effective in redu-
cing the unfavorable health outcomes during pregnancy
and postpartum [1,2]. With this aim, the World Health
Organization (WHO) recommends the introduction of
standards of care and improvements in the ANC process
[3]. Evaluation of quality of care is a key component of the
process, allowing the identification of the areas of oppor-
tunity and potential gains of introducing improvements.
In low-resource settings, assessment of the quality of care* Correspondence: svetlana.doubova@gmail.com
†Equal contributors
1Epidemiology and Health Services Research Unit CMN Siglo XXI, Mexican
Institute of Social Security, Mexico City, México
Full list of author information is available at the end of the article
© 2014 Doubova et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the oris not conducted in a routine basis because it requires de-
fined indicators and access to relevant clinical information.
In Mexico, ANC is institutionalized in public healthcare
systems; it is among the five top causes of ambulatory
care, reaching ~98% coverage [4]. However, the rates of
maternal and neonatal complications and deaths during
pregnancy and delivery are higher than expected [5,6].
The Mexican Institute of Social Security (IMSS; after its
name in Spanish) provides health care to nearly 47 million
people (40% of Mexico’s population). IMSS provides ANC
in its family medicine clinics (FMCs) and obstetric care in
its hospitals. This institution has developed clinical guide-
lines and standardized processes of ANC; it also uses the
electronic health record (EHR) for the routine provision ofal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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to evaluate comprehensively the quality of ANC and has
not used EHR information to systematize this process [7].
Under these circumstances, this study has two objectives:
first to develop quality indicators for ANC, and second to
evaluate the quality of ANC using EHR information in fam-
ily medicine clinics (FMCs) of Mexico City.
Methods
The study took place in four IMSS FMCs in Mexico City,
selected by convenience. The clinics had similar infrastruc-
ture in terms of examining rooms, laboratory, pharmacy,
EHR and institutional clinical guidelines. The clinics refer
patients to secondary level hospitals as needed through the
IMSS referral system. The population covered by these
clinics was ~585,500 people. The staff was comprised of
family doctors, nurses, social workers and dietitians. The
FMCs provide ambulatory care in the morning and even-
ing shifts in its 103 family doctors’ offices (15–30 per
clinic). All clinics above 10 examining rooms at IMSS are
fairly similar.
A two-stage mixed methods approach was used; in par-
ticular, we applied the instrument development model of
an exploratory sequential design [8]. The first stage of this
design gathered qualitative information through interviews
with key informants in the health facilities. This informa-
tion guided the quantitative phase which consisted in the
development of the items (indicators of quality of care) for
the second stage of the study.
Stage 1: Development of the list of quality of care
indicators for ANC
This stage took place from November 2009 to February
2010. The list of quality indicators was built following two
consecutive steps: (i) conducting in-depth interviews with
FMC health professionals and (ii) using a modified version
of the RAND/UCLA Appropriateness Method [9].
In-depth interviews attempted to capture the sequence
and content of the ANC process and perceived barriers in
the use of the EHR at IMSS facilities. The key informants
were three heads of clinical department, three family doc-
tors, three nurses and three social workers with ≥10 years
of experience providing ANC. Respondents were selected
according to their experience and previous participation
in implementing ANC-related programs. The researchers
conducted in-depth interviews based on eight pre-defined
topic questions. All interviews were conducted in-person
at the FMCs.
The RAND/UCLA Appropriateness Method is a suit-
able tool for developing indicators; it combines a literature
review of scientific evidence and expert group validation
[9]. The literature review collected information about the
care that pregnant women should receive. Available elec-
tronic repositories of clinical guidelines were searched,which included international [10-12] and IMSS’ guidelines
[13], as well as the indicators that the RAND group [14]
have proposed for ANC. The keywords for the search were
“antenatal care”, “prenatal care”, “guidelines”, “quality indi-
cators”, “family medicine” and “general medical practice”.
A preliminary list of indicators was developed with the
participation of two family doctors, two obstetrician-
gynecologists and two health systems researchers, a group
of experts with experience in constructing indicators. The
group received information about the objectives of the
study, a preliminary list of indicators, and the previously
mentioned guidelines. All participants rated the validity
and feasibility of the preliminary indicators by using She-
kell’s criteria [15]. As it has been the use in other studies,
o those indicators with a score >7 were taken into account
[15]. After three rounds of discussion in the group, a final
list of indicators was produced, which covered five areas:
(i) initiation and number of antenatal visits; (ii) health edu-
cation; (iii) screening for pre-existing diseases and compli-
cations; (iv) supplementation; and (v) treatment and
referral for specialized care.
Stage 2: Evaluation of the quality of care
A retrospective cohort study was conducted with women
aged 12–49 years who had completed their pregnancy in
2009 and attended to at least one ANC visit with their
family doctor in 2008–2009, as indicated above. The
source of information was the EHR. The women should
have registered the diagnosis of pregnancy according to
the codes Z321, Z34, Z35, Z36 that are in the 10th revi-
sion of the International Classification of Diseases.
The study variables were:
A) Women’s general characteristics: age, schooling,
marital status, employment and IMSS insurance status
(insured or beneficiary).
B) Medical and reproductive history: pregnancy risk,
pre-existing comorbidity, number of pregnancies, history
of premature births and low-birth weight, Rh-negative
multigravid with Rh-positive partner.
C) Nutritional status: The pre-pregnancy nutritional sta-
tus of women was classified as normal weight (body mass
index (BMI) 18.5-24.9 kg/m2), overweight (BMI 25–
29.9 kg/m2) and obese (BMI ≥30.0 kg/m2), pre- and post-
pregnancy weights, gestational weight gain and gains
above the range that the Institute of Medicine recom-
mends: BMI <18.5 kg/m2, a gain of 12.5-18 kg, BMI 18.5-
24.9 kg/m2 a gain of 11.5-16 kg, BMI 25–29.9 kg/m2 a
gain of 7.0-11.5 kg, BMI ≥ 30 kg/m2 a gain of 5–9 kg [16].
D) Pregnancy complications: urinary tract infections,
preeclampsia, gestational diabetes, hemorrhage, fetal death
and bacterial vaginosis or trichomoniasis.
E) Estimation of the quality of ANC involved the indica-
tors constructed in the first stage. To obtain a comprehen-
sive evaluation of the ANC process, we also estimated the
Doubova et al. BMC Pregnancy and Childbirth 2014, 14:168 Page 3 of 9
http://www.biomedcentral.com/1471-2393/14/168percentage of care that the women received in relation to
the recommended ANC [17]. The recommended health-
care was estimated as a proportion in which the numer-
ator was the sum of all the indicators that a woman
received and the denominator was the total number of in-
dicators for which the woman was eligible.
Data programming and statistical analysis
We used structured query language (SQL) to retrieve
data from EHR tables and create a new analytic data-
base. Non-plausible values were identified and dropped
from the analysis, for example, height <100 cm and
weight <18 kg, systolic blood pressure <50 mmHg and
diastolic blood pressure <40 mmHg. The maximum
values were predefined in the EHR.
SAS statistical package (version 9.2) was used to program
the set of complex variables for the quality of ANC indica-
tors and obtain the descriptive statistics of the variables.
The units of analysis were pregnant women. There were
three variables with missing data (marital status, occupation
and pre-pregnancy nutritional status) that were reported.
The other variables did not have any missing data.
Ethical issues
This article forms part of the study that was aimed at
developing a system for individualized evaluation and
improvement of healthcare quality of the eight most fre-
quent causes of visits at IMSS FMCs through using elec-
tronic health record information. The study protocol
was approved by the IMSS National Research and Ethics
Committees (CNIC: 2008-785-008). The data for the
analysis was obtained in each FMC. The study only
used the EHR information. All identification data of the
women in the EHR were de-identified; thus, it was not
possible to trace any of the data to the actual individual.
For this reason the informed consent was not requested.
Results
Stage1. In-depth interviews about the sequence of ANC
process at IMSS indicated that ANC begins in FMCs,
where family doctors determine whether the woman
has low or high risk pregnancy. Women with a low-risk
pregnancy receive ANC at the FMCs from the health-
care team, which includes the family doctor, a maternity
nurse, a nutritionist and a social worker. The health care
team should provide four group sessions of health educa-
tion to pregnant women. The topics covered include pro-
gression of pregnancy, pregnancy complication warning
signs, parenthood and breathing techniques for labor and
delivery, as well as post-partum information. The high-
risk pregnant women, or those who develop severe com-
plications during pregnancy such as preeclampsia, are
referred for specialized care. All pregnant women deliver
at IMSS hospitals.The EHR has functional and organizational limitations.
Only the family doctors enter routinely the data in the
EHR. The other members of the health team do not regis-
ter or register sporadically the clinical information due to
the lack of clear organizational indications; thus, they
register their activities (immunization, educational activ-
ities, etc.) in monthly record sheets and in an ad-hoc pre-
ventive care electronic system not linked to the EHR.
Furthermore, the family doctors face technical barriers to
register the information, such as system interruptions and
flaws in the design of the EHR, which impairs swift navi-
gation from one application to another; also the system
does not have locks or warnings against implausible data.
The EHR lacks a particular application for registering in-
formation on delivery and post-partum, including the con-
dition of newborns.
The findings from the in-depth interviews and literature
review resulted in a preliminary list of 27 indicators, from
which the group of experts discarded thirteen indicators be-
cause these were not feasible or informative for IMSS
(Table 1, part B). The indicator urine protein test for early
pre-eclampsia detection was discarded because it is not rou-
tinely used at FMCs. There is evidence supporting the
benefit to screen all pregnant women for virological mea-
sles, HIV and hepatitis B; nonetheless, such tests are not
available at IMSS FMCs. To mitigate this limitation, the
IMSS clinical guideline recommends identifying those pa-
tients at risk for these diseases in primary care and referring
them to the second or third level of care. Consequently,
these indicators were discarded. Pregnancy risk assessment,
measurement of blood pressure, weight and symphysis-
fundal height were also discarded because of the lack of
variability in these indicators, since such procedures must
be entered into the EHR before proceeding with other fields
of information. The remaining five indicators were dis-
carded because they were not registered routinely at the
EHR. The validation process concluded with 14 indicators
that were possible to construct using the EHR data. The in-
dicator “pregnant women who were referred to fasting
plasma glucose test during the first two ANC visits and be-
tween weeks 24 and 28 of gestation” was considered as a
surrogate of the international recommendation of perform-
ing oral glucose tolerance test, which IMSS guidelines cur-
rently do not recommend for pregnant women.
Stage 2 In 2009, 5540 women completed a pregnancy,
in which 5342 (96.1%) had at least one ANC visit and
the rest (3.9%) had the diagnosis of pregnancy without
evidence of attendance at ANC in the four clinics.
Table 2 gives the general characteristics of the participat-
ing women. Out of 5342 women, 91% were between 20 and
39 years, with a mean age of 28.8 years at the time of the
first ANC visit; 72% of them had completed high school
and college. Data on marital status were missing in 87.5%
of cases; 64.8% were insured, which means that they had a
Table 1 List of quality of care indicators
Part A. accepted indicators
Initiation and number of antenatal visits
1 Percentage of pregnant women who began ANC during the first trimester of gestation
2 Percentage of women with low risk pregnancy† who at the end of the pregnancy had at least four ANC visits
Health education
3 Percentage of pregnant women who had documented educational activities provided by the maternity
nurse or social worker
4 Percentage of overweight/obese (pre-pregnancy BMI ≥ 25 kg/m2) pregnant women who had documented
nutritional counselling provided by the nutrition service
Screening
5 Percentage of pregnant women who were referred to or had documented Rh and blood group test
6 Percentage of pregnant women who were referred to haemoglobin test during the first two ANC visits
7 Percentage of pregnant women who were referred to fasting plasma glucose test during the first two ANC
visits and between weeks 24 and 28 of gestation
8 Percentage of pregnant women who were referred to obstetric ultrasound
between weeks 18 and 22 of gestation
9 Percentage of pregnant women who were referred to VDRL test
(syphilis screening) during the first two ANC visits
Nutritional supplementation
10 Percentage of pregnant women who had prescription of folic acid during the first trimester of gestation
Treatment and referrals to the obstetrician-gynecologist
11 Percentage of pregnant women diagnosed with bacterial vaginosis or trichomoniasis, who had
vaginal metronidazol prescription in adequate doses and duration
12 Percentage of pregnant women with systolic blood pressure ≥ 140 mmHg, or diastolic blood
pressure ≥ 90 mmHg who was referred to the second or third level of care
13 Percentage of pregnant women with pre-existing degenerative chronic disease
(diabetes, hypertension, lupus, heart disease) who were referred to the second or third level of care
14 Percentage of pregnant women between 20–32 weeks with symphysis-fundal height 4 cm
less than indicated by their gestational age, who were referred to ultrasound or another level of care
Part B. Discarded indicators Reasons of elimination
1. Percentage of pregnant women who had documented
risk assessment at the first ANC visit.
These processes of care correspond
to the mandatory fields in the EHR,
so the family doctor and other
health care professional cannot
move along EHR without fill out
these fields.
2. Percentage of pregnant women who had their
blood pressure measured at each ANC visit.
3. Percentage of pregnant women who had
their weight measured at each ANC visit.
4. Percentage of pregnant women who had their
symphysis-fundal height measured at each ANC
visit from 24 weeks of gestation.
5. Percentage of pregnant women who underwent a
urine protein test at each visit from 20 weeks of gestation.
The urine protein test is not
routinely performed in most
IMSS family medicine clinics.
6. Percentage of pregnant women who
underwent screening for HIV.
Such tests are not available at
IMSS FMCs. To mitigate this
limitation, the IMSS clinical
guideline recommends
identifying those patients at risk
for these diseases in primary care
and referring them to the second
or third level of care.
7. Percentage of pregnant women who
underwent screening for hepatitis B.
8. Percentage of pregnant women who
underwent screening for measles.
9. Percentage of smoking pregnant women who
underwent smoking cessation counselling.
The information is not routinely
registered at the EHR.
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Table 1 List of quality of care indicators (Continued)
10. Percentage of pregnant without previous tetanus
toxoid immunization women who had documented
indication for this immunization during the
first trimester of gestation.
11. Percentage of multigravid Rh negative
pregnant women with
Rh-positive partner who was referred to the second or
third level of care before week 28 of gestation.
12. Percentage of pregnant women who had
premature birth (≤37 weeks) newborn.
13. Percentage of pregnant women who had
low birth weight (<2500 g) newborn.
†Low risk pregnancy: <4 points at the obstetric risk scored system of EHR.
Table 2 General characteristics of the women in the study












Married or partnership 9.3








Service workers and sailors 3.1
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occupation was missing (73%), but the recorded data shows
that most women worked as administrative staff (9.5%).
Table 3 shows the medical and reproductive history: Less
than 1% had diabetes or hypertension prior to pregnancy;
and 71.6% were nulliparous. Among multigravid women,
the median of gestations was 1 (range 1–7). Only a small
percentage (2.3%) had documented a previous premature
birth, or low birth-weight children (1.9%). There was no
record of Rh-negative multigravid with an Rh-positive part-
ner. According to the family doctors, evaluation at the first
ANC visit showed that 6.5% had a high-risk pregnancy.
Pre- and post-pregnancy weights were poorly registered.
Only 63% of women had registered a pre-pregnancy
weight and 32.1% a post-pregnancy weight. This lack of
information about weight was due to women not attend-
ing healthcare before being pregnant, and there were other
cases in which this information was not registered at the
end of pregnancy. Furthermore, 3% had non-plausible
values for this variable. Among women whose weight was
registered, almost 50% were overweight (overweight: 34.8%,
obesity: 16.8%). The average gestational weight gain was
8.4 kg, with 15.4% having a high weight gain. The complica-
tions of pregnancy registered in the EHR were pre-
eclampsia (5%) and bacterial vaginosis (1.8%); less than 1%
had bleeding and fetal death.
Table 4 shows the evaluation of the quality of ANC in
the five areas of ANC. In the area that addresses the initi-
ation and number of antenatal visits, 41% of women began
ANC in the first trimester, 42% in the second and 17% in
the third trimester (not shown in the table); 63% of
women with low risk pregnancy had made four or more
ANC visits. In the area of health education, 21% were re-
ferred for educational activities with a maternity nurse or
social worker, and only 26% of women who were over-
weight or obese from the onset of pregnancy received nu-
tritional counseling. The area of screening for pre-existing
diseases and complications showed that the most common
screening tests were for anemia (42%), gestational diabetes
(41%) and syphilis (40%), whereas only 4.4% were referredfor obstetric ultrasound. Regarding the area of supplemen-
tation, 64% had received folic acid supplementation during
the first trimester. The area of treatment for complications
and referral for specialized care showed that 92% of
women with a pre-existing chronic condition, and 69% of
women diagnosed with hypertension during pregnancy,
Table 3 Medical, reproductive history, nutritional status
and pregnancy complications






Reproductive history of multigravid women n = 1517
Number of gestations median (minimum-maximum) 1 (1–7)
Prior premature birth (<37 weeks) 2.3
Prior low birth weight (<2500 g) 1.9
Rh-negative multigravid 0.8
Rh-negative multigravid with Rh-positive partner 0.0
High risk pregnancy* 6.5
Nutritional status and gestational weight gain†





Pre-pregnancy weight, kg, mean (standard deviation) 63.6 (12.1)
Post-pregnancy weight, kg, mean (standard deviation) n = 1714
71.1 (11.9)
Gestational weight gain, kg, mean (standard deviation) 8.4 (5.4)
High gestational weight gain, % 15.4





Bacterial vaginosis, trichomoniasis 1.8
*Pregnancy risk, registered by family doctor at the first ANC visit; †Only 63% of
women had registered pre-pregnancy weight and 32.1%
post-pregnancy weight.
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with mild conditions (such as vaginal infection) received
treatment. On average, women received 32.7% of the rec-
ommended ANC.
Discussion
The study shows the feasibility of developing indicators to
assess the quality of ANC using existing data from the
EHR. It also identifies the quality of ANC as having a wide
margin for improvement in all areas of evaluation com-
prising the set of indicators, thus signaling that there are
unmet needs in the care of pregnant women. Further-
more, the findings show that the process of ANC should
be renovated at IMSS FMCs. Some of the indicators thatwere discarded signal scarcity of resources and obsoles-
cence in criteria to provide evidence-based ANC.
The method of developing the indicators is robust. The
modified version of the RAND/UCLA Appropriateness
Method combines scientific evidence and expert consen-
sus, allowing the construction of scientifically rigorous
and contextually suitable indicators that permit valid judg-
ments and reproducible evaluations [9].
The use of ANC indicators has been previously reported
in the literature; we identified one study that reported the
method followed to design and validate the indicators [17].
Other studies only reported the authors’ selection of the in-
dicators from a list of ANC procedures, without reporting
the validation method [18-21]. For example, a study in
Mexico proposed a list of 12 ANC procedures that com-
prised history-taking and diagnosis (blood and urine tests,
and history of bleeding and discharge), physical examin-
ation (blood pressure, weight, and uterine height), and pre-
ventive procedures (tetanus toxoid immunization, iron
supplements, family planning and breastfeeding counsel-
ling, and use of the health card) [18]. In Vietnam the inves-
tigators defined a typical minimum ANC content: seven
items on bio-medical assessments (body weight, blood
pressure, fundal height, fetal heart rate, vaginal examin-
ation, urine testing, and ultrasound), four items on care
provision (tetanus toxoid immunization, provision of tablets
or advice on iron/folate supplement, malaria prevention,
and preparation for safe delivery), and two items on health
promotion/education (resting and nutrition) [19]. These in-
dicators addressed a variable number of the ANC pro-
cesses, and were context-specific.
The quality indicators cannot simply be transferred from
one country to another or from one healthcare system to
another. Before using them, it is advisable to learn about
their applicability and carry out a rigorous validation [22].
In our study the indicators of RAND Group were the ref-
erent to develop the IMSS indicators, which in turn were
assessed for their validity and feasibility. Comparing with
RAND indicators (39 indicators) the list of IMSS indica-
tors was shorter, as several indicators were considered not
applicable, given that the institution did not perform some
antenatal care procedures due to resource constraints,
such as screening for HIV and hepatitis B, or the protein-
urine test.
Epidemiological information suggests that, in Mexico,
little has been achieved to improve maternal and newborn
health, specifically ANC [23]. The lack of systematic evalu-
ation of ANC quality impairs proper identification of areas
needing improvement. Although this study was conducted
in a reduced number of facilities, the set of indicators that
were developed and validated could be seen as a prelimin-
ary effort to systematize ANC evaluation, and guide the
implementation and monitoring of large-scale programs
aimed at improving the quality of ANC care.
Table 4 Quality of care
Indicators %
Initiation and number of antenatal visits
Pregnant women who began ANC during the first trimester of gestation n = 5342
40.6
Women with low risk pregnancy† who at the end of the pregnancy had at least 4 ANC visits n = 4300
63.5
Education for health
Pregnant women with documented educational activities provided by the maternity nurse or social worker n = 5342
20.7
Overweight/obese (pre-pregnancy BMI≥ 25 kg/m2) pregnant women who had documented nutritional counseling provided
by the nutrition service
n = 1754
26.0
Screening n = 5342
Pregnant women referred to or had documented Rh and blood group test 23.9
Pregnant women referred to hemoglobin test during the first 2 ANC visits 41.9
Pregnant women referred to fasting plasma glucose test during the first 2 ANC visits and between weeks 24 and 28 of gestation 41.1
Pregnant women referred to obstetric ultrasound between weeks 18 and 22 of gestation 4.4
Pregnant women referred to VDRL test (syphilis screening) during the first 2 ANC visits 40.1
Supplementation n = 2169
Pregnant women prescribed folic acid during the first trimester of gestation 64.6
Treatment and references to the obstetrician-gynecologists consultation at the second level of care
Pregnant women diagnosed with bacterial vaginosis or trichomoniasis who had vaginal metronidazol prescription n = 95
45.3
Pregnant women with systolic blood pressure ≥140 mmHg, or diastolic≥ 90 mmHg referred to the second or third level of care n = 291
69.1
Pregnant women with pre-existing degenerative chronic disease (diabetes, hypertension, lupus, heart disease) referred to
the second or third level of care
n = 54
92.6
Pregnant women between 20–32 weeks with symphysis-fundal height 4 cm less than indicated by their gestational age,
referred to ultrasound or another level of care
n = 1445
60.3
Percentage of recommended care††, mean (standard deviation) 32.7 (22.2)
n: indicates the number of women eligible for the evaluated indicator; †Low risk pregnancy: <4 points at the obstetric risk scored system of EHR; ††Proportion of
antenatal care procedures that a woman received relative the total number of indicators for which she was eligible.
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ity of scaling up the scope and rigorousness of these evalua-
tions. Nevertheless, the published experience of evaluating
quality of care using EHR data is limited in the Latin-
American region [24,25]. The results of this study stress that
the overall quality of ANC was poorly achieved, given that
pregnant women received only a third part of the recom-
mended care. This percentage was below than the reported
in the United States [17] where it reached 73% and in an-
other study conducted in Mexico, where >80% of pregnant
women received the recommended care [18]. In contrast,
pregnant women in Vietnam [19] and Brazil [20] attained
1.8% and 15% of the recommended care, respectively; yet
comparison is difficult because of differences in the analyzed
indicators and the source of information, given that these
studies did not analyze EHR data.Flaws were observed in all areas of provision of ANC,
and this study suggests specific areas that could be im-
proved. Early initiation of ANC increases the likelihood of
timely identification and appropriate management of preg-
nancy complications. In our study, less than 50% of
women began ANC during the first trimester of preg-
nancy. This result is much lower than reported in high-
income countries [26] where 66-90% begins ANC in the
first trimester. Our results are similar to those from Brazil
and Vietnam [19,20]. This indicates the need to train
health professionals and inform reproductive age women
about the importance of early ANC.
In low-risk pregnancies, four ANC visits are recom-
mended for women to receive required screening,
immunization and educational activities [10]. In the
present study 36% of low-risk pregnant women had
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number of visits, but their content that matters in provid-
ing high quality ANC. For example, according to clinical
guidelines, most of the screening activities should be per-
formed during the first ANC visit.
The key areas of health education considered to be ef-
fective in improving pregnancy outcomes include educa-
tion about a healthy diet, prevention of accidents and
early identification of warning signs of complications
[10-13]. However, we found that only 20.7% had docu-
mented educational activities with a maternity nurse or
a social worker, and 26% received nutritional counseling,
despite that half of the pregnant women were over-
weight or obese from the onset of pregnancy. This find-
ing indicates an unmet need for health education,
nutritional care, and the issue of incomplete information
in the EHR that should be seriously considered as part
of any quality of care improvement program.
Screening for pre-existing diseases and complications
requires further action that can be beneficial for preg-
nant women. Antenatal ultrasound for fetal abnormal-
ities was used in only 4.4% of women; this study allows
early detection of neural tube defects (NTDs) and intra-
uterine growth retardation, among other abnormalities,
as well as being cost-effective [11]. Mexico has a high
prevalence of NTDs [27], which justifies the need for
ultrasound studies of pregnant women.
A low blood folate level is associated with increased risk
of NTD, spontaneous abortion and low birth-weight [28].
Folic acid supplementation can reduce the incidence of
NTDs by up to 70% [29]. Nevertheless, only 64% of women
were prescribed folic acid, pointing out the need to
reinforce supplementation of folic acid by educating health
professionals and women of reproductive age.
There is a lack of continuity between the primary care
setting and the specialized care for women who develop
severe complications. In our study, only 69% of women
with a blood pressure higher than 140/90 mmHg, and
60% of those with symphysis-fundal height 4 cm below
the corresponding to their gestational age were referred
for specialized care. The rates of gestational hypertension
and low birth-weight are high among IMSS affiliates. For
example, a study conducted in 2005 in Mexico City re-
ported that 31% of maternal deaths were attributable to
pre-eclampsia and 45% had received poor healthcare [30].
The indicator of women treated for bacterial vaginosis
was only 45.3%. There is evidence of an association be-
tween bacterial vaginosis and an increased incidence of
adverse pregnancy outcomes, such as premature rupture
of membranes, preterm delivery and low birth weight
[31]. Although a recent Cochrane review [32] provides
little evidence that screening and treating all pregnant
women with bacterial vaginosis will prevent preterm
birth and its consequences. However the same reviewcommented that, when screening criteria were broad-
ened to include women with abnormal flora, there was a
47% reduction in preterm birth.
The study has several strengths. (i) The method of de-
veloping the indicators was robust and replicable. (ii) The
EHR contains routinely collected data that made the
evaluation feasible, and this was based on clinical informa-
tion from the day-to-day provision of healthcare services;
specifically for this study, the extraction and programming
of the information allowed retrospective analysis of the
data from 5342 pregnant women seen in a calendar year.
(iii) The procedure is efficient and replicable and reduces
errors in data collection making it convenient for complex
healthcare systems, such as IMSS.
However, several limitations were noted. First, our
measure of quality of ANC relies on the EHR data and
therefore could overestimate or underestimate the quality
of ANC. It is possible that some procedures might have
been performed (e.g. referral to the dietitian) during the
ANC visits without being registered or vice versa. For eth-
ical and practical reasons, it would be impossible to use
other strategies to document such procedures, e.g. direct
observation or hidden patients. However, the procedures
followed at IMSS and the experience of other studies con-
ducted at IMSS suggests that health records from FMCs,
like those included in this study, can accurately reflect the
actions taken during ANC. Second, the scope of the evalu-
ation of the quality of ANC is limited due to the lack of in-
formation regarding the delivery and post-partum period,
including the conditions of the newborns. Finally, the study
was conducted in four FMCs, which means that the results
may not be representative of all the 1400 IMSS FMCs in
Mexico. However, the methodology can be used to evaluate
and to compare the quality of ANC in other health systems
in Mexico or other countries that use EHRs for ANC.
Conclusions
This study suggests that it is feasible to develop quality in-
dicators and evaluate the quality of ANC using existing
EHR data. The evaluation shows flaws in the provision of
ANC, which can guide in a precise way the development
of strategies aimed at improving the quality of care and
the use of the EHR. The study provides a valuable experi-
ence for developing countries regarding the use of the
EHR for quality of ANC evaluation.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SVD conducted the literature review, coordinated the development,
definitions, and programming of the indicators, interpreted the data and
wrote the article. RPC conceptualized the study, participated in the
development of the indicators and contributed to drafting the article. EOP
y BHP critically reviewed the manuscript for significant intellectual content.
All authors approved the final manuscript.
Doubova et al. BMC Pregnancy and Childbirth 2014, 14:168 Page 9 of 9
http://www.biomedcentral.com/1471-2393/14/168Acknowledgments
We appreciate the panel of experts who participated in the rating of quality
of care indicators. We thank the medical directors of the participating clinics
for their collaboration in the study.Funding
This study was funded by Consejo Nacional de Ciencia y Tecnología
(CONACYT): SALUD-2005-02-14455.
Author details
1Epidemiology and Health Services Research Unit CMN Siglo XXI, Mexican
Institute of Social Security, Mexico City, México. 2Division of Social Protection
and Health, Inter American Development Bank, Mexico City, México. 3Center
for Population Health Research, National Institute of Public Health,
Cuernavaca, Mexico. 4Institute for Health Metrics and Evaluation, University of
Washington, Seattle, USA.
Received: 28 August 2013 Accepted: 3 May 2014
Published: 16 May 2014References
1. Carroli G, Rooney C, Villar J: How effective is antenatal care in preventing
maternal mortality and serious morbidity? An overview of the evidence.
Paediatr Perinat Epidemiol 2001, 15(Suppl 1):1–42.
2. Menezes EV, Yakoob MY, Soomro T, Haws RA, Darmstadt GL, Bhutta ZA:
Reducing stillbirths: prevention and management of medical disorders and
infections during pregnancy. BMC Pregnancy Childbirth 2009, 9(Suppl 1):S4.
3. World Health Organization: Department of Making Pregnancy Safer and
Department of Reproductive Health and Research: Standards of Maternal and
Neonatal Care. Geneva: WHO; 2007.
4. Velasco-Murillo V, Padilla I, Cruz De la L, Acosta-Cázares B: ENCOPREVE-
NIMSS 2003 reproductive health. Rev Med Inst Mex Seguro Soc 2006,
44(Suppl 1):S87–95.
5. UNICEF: Progreso desde la cumbre mundial en favor de la infancia. In Un
análisis estadístico. UNICEF; 2001. Available at: http://www.cinu.org.mx/
biblioteca/documentos/infancia/sgreport_adapted_stats_sp.pdf.
6. Lozano R, Wang H, Foreman KJ, Rajaratnam JK, Naghavi M, Marcus JR,
Dwyer-Lindgren L, Lofgren KT, Phillips D, Atkinson C, Lopez AD, Murray CJ:
Progress towards Millennium Development Goals 4 and 5 on maternal
and child mortality: an updated systematic analysis. Lancet 2011,
378:1139–1165.
7. Pérez-Cuevas R, Ruiz B, Reyes H, Pedrote B, Massa R, Vargas L, Sánchez L,
Estrada C, Michaus F, Castro A, Muñoz O: Implementation and evaluation
of the Family Medicine Improvement Process experimental model.
In Family medicine at the dawn of the 21st Century. Edited by García-Peña C,
Muñoz O, Durán L. Mexico: IMSS; 2005:55–74.
8. Creswell JW, Plano Clark VL: Designing and conducting mixed methods
research. 1st eds. Sage: Thousand Oaks, CA; 2007.
9. Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE: A method
for the detailed assessment of the appropriateness of medical
technologies. Inn J Technol Assess Health Care 1986, 2:53–63.
10. World Health Organization: Pregnancy, childbirth, postpartum and newborn
care - A guide for essential practice. Geneva: WHO; 2006. Available at:
http://whqlibdoc.who.int/publications/2006/924159084x_eng.pdf.
11. National Institute for Health and Clinical Excellence: Antenatal care routine
care for the healthy pregnant women. UK: Clinical Guideline; 2008.
12. Akkerman D, Cleland L, Croft G, Eskuchen K, Heim C, Levine A, Setterlund L,
Stark C, Vickers J, Westby E: Institute for Clinical Systems Improvement. Routine
Prenatal Care. Updated July 2012; Available at: https://www.icsi.org/_asset/
13n9y4/Prenatal.pdf.
13. Instituto Mexicano Del Seguro Social: Dirección de prestaciones médicas: Guía de
práctica clínica. México DF: Control prenatal con enfoque de riesgo; 2009.
14. Gifford D, Murata P, McGlynn EA: PRENATAL CARE. Pages 189-257. In
Quality of Care for Women: A Review of Selected Clinical Conditions and
Quality Indicators. Edited by Mcglynn EA, Kerr E, Damberg CL, Asch SM.
Santa Monica, Calif: RAND; 2000. Available at: http://www.rand.org/content/
dam/rand/pubs/monograph_reports/MR1284/mr1284.ch14.pdf.
15. Shekelle PG, MacLean CH, Morton SC, Wenger NS: Assessing care of
vulnerable elders: methods for developing quality indicators. Ann Intern
Med 2001, 135:647–652.16. Simas TA, Liao X, Garrison A, Sullivan GM, Howard AE, Hardy JR: Impact of
updated Institute of Medicine guidelines on prepregnancy body mass
index categorization, gestational weight gain recommendations, and
needed counseling. J Womens Health (Larchmt) 2011, 20:837–844.
17. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA:
The quality of health care delivered to adults in the United States. N Engl
J Med 2003, 348:2635–2645.
18. Barber SL: Public and private prenatal care providers in urban Mexico:
how does their quality compare? Int J Qual Health Care 2006, 18:306–313.
19. Trinh LT, Michael John D, Byles J: Antenatal care adequacy in three
provinces of Vietnam: long An, Ben Tre y Quang Ngai. Public Health
Reports 2006, 121:468–475.
20. Passos AA, Moura ER: Process indicators in the program for humanization
of the prenatal care and childbirth in Ceará State, Brazil: analysis of
historical series (2001–2006). Cad Saúde Pública 2008, 24:1572–1580.
21. Kyei NN, Chansa C, Gabrysch S: Quality of antenatal care in Zambia: a
national assessment. BMC Pregnancy Childbirth 2012, 12:151.
22. Marshall MN, Shekelle PG, McGlynn EA, Campbell S, Brook RH, Roland MO:
Can health care quality indicators be transferred between countries.
Qual Saf Health Care 2003, 12:8–12.
23. Secretaría de Salud. Dirección General de Epidemiología: Sistema nacional
de vigilancia epidemiológica: informe semanal no. 40 de vigilancia
epidemiológica de defunciones maternas. México: Secretaría de Salud; 2011.
24. Fernández A, Oviedo E: Salud electrónica en América Latina y el Caribe:
avances y desafíos. CEPAL: Santiago de Chile; 2010.
25. Williams F, Boren SA: The role of the electronic medical record (EMR) in
care delivery development in developing countries: a systematic review.
Inform Prim Care 2008, 16:139–145.
26. EURO-PERISTAT project with SCPE, EUROCAT, EURONEOSTAT: European
perinatal health report. Better statistics for better health in pregnant women
and their babies. Paris: EURO-PERISTAT; 2008.
27. Hernández-Herrera RJ, Alcalá-Galván LG, Flores-Santos R: Neural defect
prevalence in 248,352 consecutive newborns. Rev Med Inst Mex Seguro
Soc 2008, 46:201–204.
28. Scholl TO, Johnson WG: Folic acid: influence on the outcome of
pregnancy. Am J Clin Nutr 2000, 71(5 Suppl):S1295–1303.
29. Posey DL, Khoury MJ, Mulinare J, Adams MJ Jr, Ou CY: Is mutated MTHFR a
risk factor for neural tube defects? Lancet 1996, 347:686–687.
30. Pérez-Cuevas R, Doubova SV, Baridó-Murguía E, Tena-Alavez G: Quality of
care in preeclampsia. In McGraw-Hill Interamericana Editores, S.A. de C.V.
Edited by Romero-Arauz JF, Tena-Alavez G, Jiménez-Solís GA. México, D.F:
Preeclampsia. Enfermedades hipertensivas de embarazo; 2009:49–64.
31. World Health Organization: Guidelines for the management of sexually
transmitted infections. Geneva: WHO; 2005.
32. Brocklehurst P, Gordon A, Heatley E, Milan SJ: Antibiotics for treating
bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2013,
1, CD000262.
doi:10.1186/1471-2393-14-168
Cite this article as: Doubova et al.: Evaluation of the quality of antenatal
care using electronic health record information in family medicine
clinics of Mexico City. BMC Pregnancy and Childbirth 2014 14:168.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
